iScience,
Год журнала:
2024,
Номер
27(7), С. 110309 - 110309
Опубликована: Июнь 20, 2024
Mitochondrial
dysfunction
and
Müller
cells
gliosis
are
significant
pathological
characteristics
of
retinal
degeneration
(RD)
causing
blinding.
Stem
cell
therapy
is
a
promising
treatment
for
RD,
the
recently
accepted
therapeutic
mechanism
fusion
induced
materials
transfer.
However,
whether
including
mitochondrial
transfer
between
grafted
stem
recipient's
contribute
to
suppressing
unclear.
In
present
study,
we
demonstrated
that
bone
marrow
mesenchymal
(BMSCs)
transferred
mitochondria
by
tunneling
nanotubes.
BMSCs-derived
(BMSCs-mito)
were
integrated
into
network
cells,
improving
function,
reducing
oxidative
stress
gliosis,
which
protected
visual
function
partially
in
degenerative
rat
retina.
RNA
sequencing
analysis
revealed
BMSCs-mito
increased
DNA
(mtDNA)
content
facilitated
damaged
cells.
It
suggests
from
BMSCs
remodels
metabolism
suppresses
gliosis;
thus,
delaying
progression
RD.
Cells,
Год журнала:
2024,
Номер
13(2), С. 198 - 198
Опубликована: Янв. 21, 2024
Glaucoma
is
a
group
of
ocular
diseases
that
cause
irreversible
blindness.
It
characterized
by
multifactorial
degeneration
the
optic
nerve
axons
and
retinal
ganglion
cells
(RGCs),
resulting
in
loss
vision.
Major
components
glaucoma
pathogenesis
include
glia-driven
neuroinflammation
impairment
mitochondrial
dynamics
bioenergetics,
leading
to
neurodegeneration.
In
this
review
article,
we
summarize
current
evidence
for
emerging
role
apolipoprotein
A-I
binding
protein
(AIBP)
as
an
important
anti-inflammatory
neuroprotective
factor
retina.
Due
its
association
with
toll-like
receptor
4
(TLR4),
extracellular
AIBP
selectively
removes
excess
cholesterol
from
plasma
membrane
inflammatory
activated
cells.
This
results
reduced
expression
TLR4-associated,
cholesterol-rich
lipid
rafts
inhibition
downstream
signaling.
Intracellular
localized
mitochondria
modulates
mitophagy
through
ubiquitination
mitofusins
1
2.
Importantly,
elevated
intraocular
pressure
induces
deficiency
mouse
models
human
glaucomatous
leads
activation
TLR4
Müller
glia,
triggering
dysfunction
both
RGCs
compromising
visual
function
model.
Conversely,
restoring
retina
reduces
neuroinflammation,
prevents
death,
protects
function.
These
provide
new
insight
into
mechanism
suggest
therapeutic
potential
treatment
glaucoma.
Abstract
Glaucoma,
a
blind‐leading
disease
largely
since
chronic
pathological
intraocular
high
pressure
(ph‐IOP).
Hitherto,
it
is
reckoned
incurable
for
irreversible
neural
damage
and
challenges
in
managing
IOP.
Thus,
significant
to
develop
neuroprotective
strategies.
Ferroptosis,
initially
identified
as
an
iron‐dependent
regulated
death
that
triggers
Fenton
reactions
culminates
lipid
peroxidation
(LPO),
has
emerged
focal
point
multiple
tumors
neurodegenerative
diseases.
Researches
show
iron
homeostasis
play
critical
roles
the
optic
nerve
(ON)
retinal
ganglion
cells
(RGCs),
suggesting
targeted
treatments
could
be
effective.
In
glaucoma,
apart
from
lesions,
disrupted
metal
balance
increased
oxidative
stress
trabecular
meshwork
(TM)
are
observed.
These
disturbances
lead
extracellular
matrix
excretion
disorders,
known
sclerotic
mechanisms,
resulting
refractory
blockages.
Importantly,
stress,
downstream
effect
of
ferroptosis,
also
key
factor
cell
senescence.
It
plays
crucial
role
both
etiology
risk
glaucoma.
Moreover,
ferroptosis
induces
non‐infectious
inflammation,
which
exacerbate
glaucomatous
injury.
Therefore,
relevance
glaucoma
extensive
multifaceted.
this
review,
study
delves
into
current
understanding
mechanisms
aiming
provide
clues
inform
clinical
therapeutic
practices.
International Journal of Ophthalmology,
Год журнала:
2023,
Номер
16(5), С. 811 - 823
Опубликована: Апрель 28, 2023
Glaucoma
is
a
kind
of
optic
neuropathy
mainly
manifested
in
the
permanent
death
retinal
ganglion
cells
(RGCs),
atrophy
nerve,
and
loss
visual
ability.
The
main
risk
factors
for
glaucoma
consist
pathological
elevation
intraocular
pressure
(IOP)
aging.
Although
mechanism
remains
an
open
question,
theory
related
to
mitochondrial
dysfunction
has
been
emerging
last
decade.
Reactive
oxygen
species
(ROS)
from
respiratory
chain
are
abnormally
produced
as
result
dysfunction.
Oxidative
stress
takes
place
when
cellular
antioxidant
system
fails
remove
excessive
ROS
promptly.
Meanwhile,
more
studies
show
that
there
other
common
features
glaucoma,
including
damage
DNA
(mtDNA),
defective
quality
control,
ATP
reduction,
changes,
which
worth
summarizing
further
exploring.
purpose
this
review
explore
glaucomatous
neuropathy.
Based
on
mechanism,
existing
therapeutic
options
summarized,
medications,
gene
therapy,
red-light
promising
provide
feasible
neuroprotective
ideas
treatment
glaucoma.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(3), С. 2573 - 2573
Опубликована: Янв. 29, 2023
Common
risk
factors
for
many
ocular
pathologies
involve
non-pathologic,
age-related
damage
to
the
optic
nerve.
Understanding
mechanisms
of
changes
can
facilitate
targeted
treatments
that
arise
at
any
point
in
life.
In
this
review,
we
examine
these
age-related,
neurodegenerative
nerve,
contextualize
from
anatomic
molecular
level,
and
appreciate
their
relationship
with
pathophysiology.
From
simple
structural
mechanical
nerve
head
(ONH),
epigenetic
biochemical
alterations
tissue
environment,
multiple
age-dependent
drive
extracellular
matrix
(ECM)
remodeling,
retinal
ganglion
cell
(RGC)
loss,
lowered
regenerative
ability
respective
axons.
conjunction,
aging
decreases
myelin
preserve
maximal
conductivity,
even
“successfully”
regenerated
Glial
cells,
however,
regeneratively
overcompensate
result
a
microenvironment
promotes
RGC
axonal
death.
Better
elucidating
neurodegeneration
remains
interest,
specifically
investigating
human
ECM,
RGCs,
axons,
oligodendrocytes,
astrocytes;
clarifying
exact
processes
aged
connective
ultrastructural
impacts;
developing
novel
technologies
pharmacotherapies
target
known
genetic,
biochemical,
matrisome,
neuroinflammatory
markers.
Management
models
should
account
when
addressing
glaucoma,
diabetic
retinopathy,
other
blinding
diseases.
Proceedings of the National Academy of Sciences,
Год журнала:
2024,
Номер
121(36)
Опубликована: Авг. 27, 2024
Characterized
by
progressive
degeneration
of
retinal
ganglion
cells
(RGCs)
and
vision
loss,
glaucoma
is
the
primary
cause
irreversible
blindness,
incurable
affecting
over
78
million
patients.
However,
pathogenic
mechanisms
leading
to
glaucoma-induced
RGC
loss
are
incompletely
understood.
Unexpectedly,
we
found
that
cGAS-STING
(2'3'-cyclic
GMP-AMP-stimulator
interferon
genes)
signaling,
which
surveils
displaced
double-stranded
DNA
(dsDNA)
in
cytosol
initiates
innate
immune
responses,
was
robustly
activated
during
microglia
distinct
murine
models.
Global
or
microglial
deletion
STING
markedly
relieved
symptoms
protected
while
mice
bearing
genetic
supersensitivity
aggravated
neuroinflammation
loss.
Mechanistically,
dsDNA
from
tissue
injury
causing
deleterious
macroglia
reactivity
retinas
cytokine-mediated
microglia-macroglia
interactions,
progressively
driving
apoptotic
death
RGCs.
Remarkably,
preclinical
investigations
targeting
signaling
intraocular
injection
TBK1i
anti-IFNAR1
antibody
prevented
losses
RGCs
vision.
Therefore,
unravel
an
essential
role
underlying
pathogenesis
suggest
promising
therapeutic
strategies
for
treating
this
devastating
disease.
Clinical and Experimental Ophthalmology,
Год журнала:
2023,
Номер
51(6), С. 627 - 641
Опубликована: Июнь 15, 2023
Abstract
The
retinal
ganglion
cells
(RGCs)
are
the
sole
output
neurons
that
connect
information
from
retina
to
brain.
Optic
neuropathies
such
as
glaucoma,
trauma,
inflammation,
ischemia
and
hereditary
optic
neuropathy
can
cause
RGC
loss
axon
damage,
lead
partial
or
total
of
vision,
which
is
an
irreversible
process
in
mammals.
accurate
diagnoses
crucial
for
timely
treatments
prevent
irrevocable
RGCs
loss.
After
severe
ON
damage
neuropathies,
promoting
regeneration
vital
restoring
vision.
Clearance
neuronal
debris,
decreased
intrinsic
growth
capacity,
presence
inhibitory
factors
have
been
shown
contribute
failure
post‐traumatic
CNS
regeneration.
Here,
we
review
current
understanding
manifestations
various
common
neuropathies.
We
also
summarise
known
mechanisms
survival
mammals,
including
specific
signalling
pathways,
key
transcription
factors,
reprogramming
genes,
inflammation‐related
stem
cell
therapy,
combination
therapies.
Significant
differences
subtypes
regenerative
capacity
after
injury
found.
Finally,
highlight
developmental
states
non‐mammalian
species
capable
regenerating
axons
injury,
cellular
state
neural
repair.
Pharmaceuticals,
Год журнала:
2023,
Номер
16(9), С. 1193 - 1193
Опубликована: Авг. 22, 2023
Glaucoma,
a
group
of
diseases
characterized
by
progressive
retinal
ganglion
cell
loss,
cupping
the
optic
disc,
and
typical
pattern
visual
field
defects,
is
leading
cause
severe
impairment
blindness
worldwide.
Elevated
intraocular
pressure
(IOP)
risk
factor
for
glaucoma
development.
However,
can
also
develop
at
normal
levels.
An
increased
susceptibility
cells
to
IOP,
systemic
vascular
dysregulation,
endothelial
dysfunction,
autoimmune
imbalances
have
been
suggested
as
playing
role
in
pathophysiology
normal-tension
glaucoma.
Since
inflammation
oxidative
stress
play
all
forms
glaucoma,
goal
this
review
article
present
an
overview
inflammatory
pro-oxidant
mechanisms
discuss
immunomodulatory
antioxidant
treatment
approaches.
Cell Proliferation,
Год журнала:
2024,
Номер
57(11)
Опубликована: Июль 31, 2024
Abstract
Retinal
ischemia/reperfusion
injury
(RI/R)
is
a
common
pathological
process
in
ophthalmic
diseases,
which
can
cause
severe
visual
impairment.
The
mechanisms
underlying
RI/R
damage
and
repair
are
still
unclear.
Scholars
actively
exploring
effective
intervention
strategies
to
restore
impaired
function.
With
the
development
of
nucleic
acid
nanomaterials,
tetrahedral
framework
acids
(tFNAs)
have
shown
promising
therapeutic
potential
various
fields
such
as
stem
cells,
biosensors,
tumour
treatment
due
their
excellent
biological
properties.
Besides,
miRNA‐22‐3p
(miR‐22),
an
important
regulatory
factor
neural
tissue,
has
been
proven
positive
effects
neurodegenerative
diseases.
By
stably
constructing
complex
miR22
(tFNAs‐miR22),
we
observed
that
tFNAs‐miR22
had
effect
on
retinal
tissue.
Previous
studies
tFNAs
effectively
deliver
miR‐22
into
damaged
neurons,
subsequently
exerting
neuroprotective
effects.
Interestingly,
found
there
was
certain
synergistic
between
miR‐22.
selectively
activated
ERK1/2
signalling
pathway
reduce
neuronal
apoptosis,
accelerate
cell
proliferation,
synaptic
functional
activity.
In
this
study,
established
simple
yet
small
molecule
drug
for
may
become
neuroprotectant
treating
type
vision
impairment
disease
future.